A New Frontier
in the Understanding of Cardiac Arrhythmias

A Computer

Cardiac arrhythmias impact millions of people across the globe, increasing the risk of serious health-related issues, including stroke and even death.¹ Yet, the current standard of care — including antiarrhythmic drugs and blind, anatomical-based ablation therapy — is suboptimal and is associated with severe side effects and disappointingly low success rates.²

Vektor Medical, Inc. aims to revolutionize arrhythmia therapy with a transformative technology focused on our understanding of cardiac arrhythmias. Vektor’s technology is designed to supplement clinical management of arrhythmias by providing physicians with actionable information to evaluate, locate, and potentially treat the arrhythmia using its non-invasive, rapid, and workflow-optimized “vMap™” technology.

Rapid
Non-Invasive
Optimized Workflow

100%

Vektor’s technology has been developed to provide electrophysiologists with information on arrhythmias in all four of the heart chambers.

¹ January CT, Wann LS, Alpert JS, et al. JACC 2014;64(21):2246–80; Atrial fibrillation: management, National Institute for Health and Care Excellence, 2014; Nichol G, Thomas E, Callaway CW et al. Jama 2008;300:1423-31. ² Saksena S, Slee A, Waldo AL et al. JACC 2011;58:1975-85; Verma et al. STAR-AF2 Trial (NEJM 2015)